Pflug Koory’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $35.3K | Hold |
225
| – | – | 0.01% | 256 |
|
|
2026
Q1 | $34.4K | Hold |
225
| – | – | 0.02% | 249 |
|
|
2025
Q4 | $31K | Sell |
225
-300
| -57% | -$39.3K | 0.01% | 258 |
|
|
2025
Q3 | $67.3K | Hold |
525
| – | – | 0.03% | 212 |
|
|
2025
Q2 | $63.5K | Hold |
525
| – | – | 0.03% | 214 |
|
|
2025
Q1 | $58.5K | Hold |
525
| – | – | 0.03% | 212 |
|
|
2024
Q4 | $51.1K | Hold |
525
| – | – | 0.03% | 219 |
|
|
2024
Q3 | $60.4K | Buy |
+525
| New | +$59.6K | 0.03% | 215 |
|
|
2024
Q1 | $53.2K | Hold |
550
| – | – | 0.03% | 219 |
|
|
2023
Q4 | $55.5K | Hold |
550
| – | – | 0.03% | 221 |
|
|
2023
Q3 | $56K | Hold |
550
| – | – | 0.03% | 214 |
|
|
2023
Q2 | $55.5K | Hold |
550
| – | – | 0.03% | 224 |
|
|
2023
Q1 | $50.6K | Hold |
550
| – | – | 0.03% | 231 |
|
|
2022
Q4 | $50K | Hold |
550
| – | – | 0.03% | 231 |
|
|
2022
Q3 | $42K | Hold |
550
| – | – | 0.03% | 245 |
|
|
2022
Q2 | $46K | Hold |
550
| – | – | 0.03% | 243 |
|
|
2022
Q1 | $48K | Sell |
550
-75
| -12% | -$6.49K | 0.02% | 257 |
|
|
2021
Q4 | $55K | Hold |
625
| – | – | 0.03% | 254 |
|
|
2021
Q3 | $51K | Sell |
625
-185
| -23% | -$16.6K | 0.03% | 248 |
|
|
2021
Q2 | $74K | Buy |
810
+100
| +14% | +$8.9K | 0.04% | 223 |
|
|
2021
Q1 | $61K | Buy |
710
+225
| +46% | +$20.2K | 0.03% | 226 |
|
|
2020
Q4 | $46K | Hold |
485
| – | – | 0.03% | 241 |
|
|
2020
Q3 | $42K | Buy |
485
+65
| +15% | +$5.63K | 0.03% | 239 |
|
|
2020
Q2 | $37K | Hold |
420
| – | – | 0.03% | 240 |
|
|
2020
Q1 | $35K | Sell |
420
-13
| -3% | -$1.16K | 0.03% | 230 |
|
|
2019
Q4 | $41K | Hold |
433
| – | – | 0.03% | 241 |
|
|
2019
Q3 | $38K | Hold |
433
| – | – | 0.03% | 241 |
|
|
2019
Q2 | $40K | Sell |
433
-50
| -10% | -$4.23K | 0.03% | 232 |
|
|
2019
Q1 | $42K | Hold |
483
| – | – | 0.03% | 235 |
|
|
2018
Q4 | $37K | Hold |
483
| – | – | 0.03% | 229 |
|
|
2018
Q3 | $37K | Hold |
483
| – | – | 0.03% | 237 |
|
|
2018
Q2 | $33K | Hold |
483
| – | – | 0.03% | 243 |
|
|
2018
Q1 | $35K | Hold |
483
| – | – | 0.03% | 233 |
|
|
2017
Q4 | $36K | Hold |
483
| – | – | 0.03% | 232 |
|
|
2017
Q3 | $37K | Hold |
483
| – | – | 0.03% | 233 |
|
|
2017
Q2 | $36K | Hold |
483
| – | – | 0.03% | 239 |
|
|
2017
Q1 | $32K | Hold |
483
| – | – | 0.03% | 236 |
|
|
2016
Q4 | $32 | Buy |
+483
| New | +$31.3K | 0.03% | 224 |
|
Other funds holding NVS
LMFP
SI
GGI
QCM
MIM
DLA
BCAM
MGIA
ERP
Pflug Koory's NVS Position: Q2 2026 in Review
Pflug Koory held its Novartis (NVS) position steady in Q2 2026 at 225 shares worth $35.3K. The position accounts for 0.01% of the portfolio, ranked #256.
Pflug Koory first reported a position in NVS in Q4 2016 and has held it in 38 quarters since. The position peaked at $74K in Q2 2021. 366 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Pflug Koory held 225 shares of Novartis worth $35.3K as of Q2 2026.
- Pflug Koory left its Novartis share count unchanged in Q2 2026.
- Novartis made up 0.01% of Pflug Koory's portfolio in Q2 2026, its #256 holding.
- Pflug Koory first reported a position in Novartis in Q4 2016 and has held it in 38 quarters since.
- Pflug Koory's Novartis position peaked at $74K in Q2 2021.
- 366 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Pflug Koory's 13F filing for Q2 2026, filed 21 Jul 2026.